Literature DB >> 22576695

Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results.

Jonas Busch1, Carsten Stephan, Annett Klutzny, Stefan Hinz, Carsten Kempkensteffen, Ergin Kilic, Michael Lein, Steffen Weikert, Kurt Miller, Ahmed Magheli.   

Abstract

PURPOSE: The impact of positive surgical margins (PSM) on biochemical recurrence (BCR) has been heavily debated in laparoscopic radical prostatectomy (LRP). The aim of this study was to investigate the impact of PSM on BCR following LRP in patients with extended follow-up.
METHODS: Retrospective chart review of 1,845 patients who underwent LRP from 1999 to 2007. Predictors of PSM and BCR were identified utilizing univariate and multivariable logistic and Cox regression analyses, respectively.
RESULTS: Five hundred and thirty-seven patients (29.1%) had a PSM. Median postoperative follow-up was 56 months. 10-year BCR-free survival was 59.2 and 82.9% for patients with and without PSM, respectively (p < 0.0001). Clinical stage T2 (OR 1.66; CI 1.23-2.25; p = 0.001), a biopsy Gleason sum > 7 (OR 1.84; CI 1.06-3.18; p = 0.031) and preoperative prostate-specific antigen (PSA) levels of 10-20 ng/mL (OR 1.58; CI 1.12-2.23; p = 0.010) and >20 ng/mL (OR 6.82; CI 3.51-13.27; p < 0.0001) were independent predictors of PSM. Prostate size was inversely associated with PSM (OR 0.99; CI 0.98-1.00; p = 0.002). On multivariable analysis, LRP Gleason score of 7 (HR 2.45; CI 1.67-3.40; p < 0.0001) and >7 (HR 4.76; CI 3.15-7.19; p < 0.0001), PSM (HR 1.49; CI 1.14-2.00; p = 0.003), advanced pathological stages (p < 0.001), and PSA 10-20 ng/mL (HR 1.46; CI 1.13-1.89; p = 0.004) were independent predictors of BCR.
CONCLUSIONS: We demonstrated the independent predictive value of PSM for BCR in our LRP cohort with extended follow-up. Our results could potentially be transferred to robotic RP, in which long-term follow-up is lacking.

Entities:  

Mesh:

Year:  2012        PMID: 22576695     DOI: 10.1007/s00345-012-0866-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  21 in total

1.  Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.

Authors:  Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching.

Authors:  Ahmed Magheli; Mark L Gonzalgo; Li-Ming Su; Thomas J Guzzo; George Netto; Elizabeth B Humphreys; Misop Han; Alan W Partin; Christian P Pavlovich
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

3.  Laparoscopic radical prostatectomy: initial short-term experience.

Authors:  W W Schuessler; P G Schulam; R V Clayman; L R Kavoussi
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

Review 4.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers.

Authors:  Rafael F Coelho; Bernardo Rocco; Manoj B Patel; Marcelo A Orvieto; Sanket Chauhan; Vincenzo Ficarra; Sara Melegari; Kenneth J Palmer; Vipul R Patel
Journal:  J Endourol       Date:  2010-10-13       Impact factor: 2.942

5.  Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 procedures.

Authors:  Alexandre Paul; Guillaume Ploussard; Nathalie Nicolaiew; Evanguelos Xylinas; Norman Gillion; Alexandre de la Taille; Dimitri Vordos; Andras Hoznek; René Yiou; Claude Clément Abbou; Laurent Salomon
Journal:  Eur Urol       Date:  2009-09-17       Impact factor: 20.096

6.  3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the United States.

Authors:  Christian P Pavlovich; Bruce J Trock; Aaron Sulman; Andrew A Wagner; Lynda Z Mettee; Li-Ming Su
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

7.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

8.  Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 2000 cases.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Panagiotis Kallidonis; Evangelos N Liatsikos
Journal:  J Endourol       Date:  2008-10       Impact factor: 2.942

9.  Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience.

Authors:  Karim Touijer; Fernando P Secin; Angel M Cronin; Darren Katz; Fernando Bianco; Kinjal Vora; Victor Reuter; Andrew J Vickers; Bertrand Guillonneau
Journal:  Eur Urol       Date:  2008-11-06       Impact factor: 20.096

10.  Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy.

Authors:  Diederik M Somford; Inge M van Oort; Jean-Pierre Cosyns; J Alfred Witjes; Lambertus A L M Kiemeney; Bertrand Tombal
Journal:  World J Urol       Date:  2011-01-15       Impact factor: 4.226

View more
  2 in total

1.  Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis.

Authors:  Yang Meng; He Li; Peng Xu; Jia Wang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team's experience on 1,600 consecutive cases.

Authors:  Paolo Verze; Salvatore Scuzzarella; Giorgio R Martina; Pierluigi Giummelli; Federico Cantoni; Vincenzo Mirone
Journal:  World J Urol       Date:  2013-03-17       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.